Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? : editorial
María-Isabel Farfan-Portet; Sophie Gerkens; Isabelle Lepage-Nefkens; Irmgard Vinck; Frank Hulstaert
| Year of publication: |
2014
|
|---|---|
| Authors: | Farfan-Portet, María-Isabel ; Gerkens, Sophie ; Lepage-Nefkens, Isabelle ; Vinck, Irmgard ; Hulstaert, Frank |
| Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 15.2014, 3, p. 223-228
|
| Subject: | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry | Gesundheitskosten | Health care costs | Arzneimittelmarkt | Pharmaceutical market |
| Extent: | graph. Darst. |
|---|---|
| Type of publication: | Article |
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10010361510